{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces\r\n","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","metadata_created":"2019-02-01T15:40:39.119808","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2019-02-01T15:40:39.119815","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2019-02-01","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["fièvre Q","thérapie cellulaire","vaccination","poliomyélite","programmes d’immunisation","développement de vaccins","l'épidémiologie appliquée des maladies infectieuses","maladies infectieuses","médecine familiale","promotion de la vaccination contre l'influenza","vaccination contre l'influenza"],"en":["live cell therapy","Q fever outbreak","Q fever outbreakv","Q fever in Germany","National Advisory Committee on Immunization","NACI","Seasonal Influenza Vaccine","vaccine","polio","varicella vaccine","varicella","vaccine development","vaccine innovation","infleunza immunization","Infectious Disease Epidemiology","Infectious Disease"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 41-10, le 1er octobre 2015 : Vaccins","en":"CCDR: Volume 41-10, October 1, 2015: Vaccines"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f457057c-e897-472a-9623-c0581288d070","related_relationship":"","name_translated":{"fr":"RMTC : Volume 41-10, le 1er octobre 2015 : Vaccins","en":"CCDR: Volume 41-10, October 1, 2015: Vaccines"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 41-10, October 1, 2015: Vaccines","language":["en"],"created":"2019-02-01T15:40:40.376583","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41-10-october-1-2015-vaccines.html","last_modified":null,"position":0,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6514d323-3843-49d4-a1da-dc31f4cc1f10","related_relationship":"","name_translated":{"fr":"RMTC : Volume 41-10, le 1er octobre 2015 : Vaccins","en":"CCDR: Volume 41-10, October 1, 2015: Vaccines"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 41-10, October 1, 2015: Vaccines","language":["fr"],"created":"2019-02-01T15:40:40.376591","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41-10-1er-octobre-2015-vaccins.html","last_modified":null,"position":1,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"id":"461a15cd-d210-49e7-88d2-553db8e6bd23","character_set":"","state":"active","name_translated":{"fr":"RMTC : Volume 41-10, le 1er octobre 2015 : Vaccins","en":"CCDR: Volume 41-10, October 1, 2015: Vaccines"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 41-10, October 1, 2015: Vaccines","language":["en"],"created":"2019-02-01T15:40:40.376594","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/15vol41/dr-rm41-10/assets/pdf/15vol41_10-eng.pdf","last_modified":null,"position":2,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"id":"2fc60258-74a1-4783-827e-1a0f92684800","character_set":"","state":"active","name_translated":{"fr":"RMTC : Volume 41-10, le 1er octobre 2015 : Vaccins","en":"CCDR: Volume 41-10, October 1, 2015: Vaccines"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 41-10, October 1, 2015: Vaccines","language":["fr"],"created":"2019-02-01T15:40:40.376596","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/15vol41/dr-rm41-10/assets/pdf/15vol41_10-fra.pdf","last_modified":null,"position":3,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"575b1ce7-684b-46f7-8356-984162aa8b5a","related_relationship":"","name_translated":{"fr":"Éclosion de fièvre Q associée à la thérapie cellulaire chez les personnes s’étant rendues en Allemagne – États-Unis et Canada, 2014 : une coédition","en":"Q fever outbreak among travelers to Germany associated with live cell therapy — United States and Canada, 2014: a co-publication"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Q fever outbreak among travelers to Germany associated with live cell therapy — United States and Canada, 2014: a co-publication","language":["en"],"created":"2019-02-01T15:40:40.376599","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41-10-october-1-2015-vaccines/ccdr-volume-41-10-october-1-2015-vaccines.html","last_modified":null,"position":4,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5da66f57-0227-41e1-8575-4812acc2d494","related_relationship":"","name_translated":{"fr":"Éclosion de fièvre Q associée à la thérapie cellulaire chez les personnes s’étant rendues en Allemagne – États-Unis et Canada, 2014 : une coédition","en":"Q fever outbreak among travelers to Germany associated with live cell therapy — United States and Canada, 2014: a co-publication"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Q fever outbreak among travelers to Germany associated with live cell therapy — United States and Canada, 2014: a co-publication","language":["fr"],"created":"2019-02-01T15:40:40.376601","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41-10-1er-octobre-2015-vaccins/rmtc-volume-41-10-1er-octobre-2015-vaccins.html","last_modified":null,"position":5,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"833b3f85-c217-412e-9870-c5893537607d","related_relationship":"","name_translated":{"fr":"Résumé de la Déclaration sur la vaccination antigrippale pour la saison 2015-2016 du Comité consultatif national de l’immunisation (CCNI)","en":"Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2015–2016"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2015–2016","language":["en"],"created":"2019-02-01T15:40:40.376604","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41-10-october-1-2015-vaccines/ccdr-volume-41-10-october-1-2015-vaccines-1.html","last_modified":null,"position":6,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"92c987b4-8bcc-4b82-8b32-b5b3cd92b869","related_relationship":"","name_translated":{"fr":"Résumé de la Déclaration sur la vaccination antigrippale pour la saison 2015-2016 du Comité consultatif national de l’immunisation (CCNI)","en":"Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2015–2016"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2015–2016","language":["fr"],"created":"2019-02-01T15:40:40.376606","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41-10-1er-octobre-2015-vaccins/rmtc-volume-41-10-1er-octobre-2015-vaccins-1.html","last_modified":null,"position":7,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"dacbbe1f-ac4e-4169-bf48-ed299ae62fe1","related_relationship":"","name_translated":{"fr":"La phase finale de l’éradication de la poliomyélite : Pourquoi l’immunisation et la surveillance continue sont essentielles","en":"The polio eradication endgame: Why immunization and continued surveillance is critical"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The polio eradication endgame: Why immunization and continued surveillance is critical","language":["en"],"created":"2019-02-01T15:40:40.376609","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41-10-october-1-2015-vaccines/ccdr-volume-41-10-october-1-2015-vaccines-2.html","last_modified":null,"position":8,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"080188fd-e8df-4056-938c-89b1dadc3a07","related_relationship":"","name_translated":{"fr":"La phase finale de l’éradication de la poliomyélite : Pourquoi l’immunisation et la surveillance continue sont essentielles","en":"The polio eradication endgame: Why immunization and continued surveillance is critical"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The polio eradication endgame: Why immunization and continued surveillance is critical","language":["fr"],"created":"2019-02-01T15:40:40.376612","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41-10-1er-octobre-2015-vaccins/rmtc-volume-41-10-1er-octobre-2015-vaccins-2.html","last_modified":null,"position":9,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"68b5eff6-6d31-41c7-ab24-153f477f6629","related_relationship":"","name_translated":{"fr":"Un petit souci : Pourquoi les programmes d’immunisation contre la varicelle sont importants","en":"A spot of bother: Why varicella vaccine programs matter"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"A spot of bother: Why varicella vaccine programs matter","language":["en"],"created":"2019-02-01T15:40:40.376614","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41-10-october-1-2015-vaccines/ccdr-volume-41-10-october-1-2015-vaccines-3.html","last_modified":null,"position":10,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"540459f6-40cc-412e-8301-50aafce07a76","related_relationship":"","name_translated":{"fr":"Un petit souci : Pourquoi les programmes d’immunisation contre la varicelle sont importants","en":"A spot of bother: Why varicella vaccine programs matter"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"A spot of bother: Why varicella vaccine programs matter","language":["fr"],"created":"2019-02-01T15:40:40.376617","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41-10-1er-octobre-2015-vaccins/rmtc-volume-41-10-1er-octobre-2015-vaccins-3.html","last_modified":null,"position":11,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5748d7cf-728f-4783-92b3-eb6edb2e518d","related_relationship":"","name_translated":{"fr":"Innovations en matière de développement de vaccins et de surveillance","en":"Innovations in vaccine development and surveillance"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Innovations in vaccine development and surveillance","language":["en"],"created":"2019-02-01T15:40:40.376619","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41-10-october-1-2015-vaccines/ccdr-volume-41-10-october-1-2015-vaccines-4.html","last_modified":null,"position":12,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"39e79d3d-f3c9-4ef9-8817-5c00a495a413","related_relationship":"","name_translated":{"fr":"Innovations en matière de développement de vaccins et de surveillance","en":"Innovations in vaccine development and surveillance"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Innovations in vaccine development and surveillance","language":["fr"],"created":"2019-02-01T15:40:40.376622","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41-10-1er-octobre-2015-vaccins/rmtc-volume-41-10-1er-octobre-2015-vaccins-4.html","last_modified":null,"position":13,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"125edd12-8b77-4b4e-8108-6e00970d3165","related_relationship":"","name_translated":{"fr":"Campagne de promotion de la vaccination contre l'influenza","en":"Influenza Immunization Awareness Campaign"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Influenza Immunization Awareness Campaign","language":["en"],"created":"2019-02-01T15:40:40.376624","url":"http://immunize.ca/en/events/influenza-imm-campaign.aspx","last_modified":null,"position":14,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"72b604a1-3ff6-4cfd-bb7a-df206462aac0","related_relationship":"","name_translated":{"fr":"Campagne de promotion de la vaccination contre l'influenza","en":"Influenza Immunization Awareness Campaign"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Influenza Immunization Awareness Campaign","language":["fr"],"created":"2019-02-01T15:40:40.376627","url":"http://immunize.ca/fr/events/influenza-imm-campaign.aspx","last_modified":null,"position":15,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3de5f673-b580-4585-8e89-15797abe7be9","related_relationship":"","name_translated":{"fr":"Conférence scientifique européenne sur l'épidémiologie appliquée des maladies infectieuses (European Scientific Conference on Applied Infectious Disease Epidemiology [ESCAIDE]","en":"European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE)","language":["en"],"created":"2019-02-01T15:40:40.376629","url":"http://ecdc.europa.eu/en/escaide/Pages/ESCAIDE.aspx","last_modified":null,"position":16,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"66612d34-89df-425d-87be-c865c3a27185","related_relationship":"","name_translated":{"fr":"Conférence scientifique européenne sur l'épidémiologie appliquée des maladies infectieuses (European Scientific Conference on Applied Infectious Disease Epidemiology [ESCAIDE]","en":"European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE)","language":["fr"],"created":"2019-02-01T15:40:40.376632","url":"http://ecdc.europa.eu/en/escaide/Pages/ESCAIDE.aspx","last_modified":null,"position":17,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7340ecb3-85af-439b-b775-f0c09d8cb16e","related_relationship":"","name_translated":{"fr":"Forum en médecine familiale","en":" Family Medicine Forum"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":" Family Medicine Forum","language":["en"],"created":"2019-02-01T15:40:40.376634","url":"http://fmf.cfpc.ca/","last_modified":null,"position":18,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e0171971-ea47-4d2c-852a-de15a35eca28","related_relationship":"","name_translated":{"fr":"Forum en médecine familiale","en":" Family Medicine Forum"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":" Family Medicine Forum","language":["fr"],"created":"2019-02-01T15:40:40.376637","url":"http://fmf.cfpc.ca/fr/","last_modified":null,"position":19,"revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4","resource_type":"website"}],"place_of_publication":[],"num_resources":20,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2015-10-01 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"47d89dbf-881c-4d2e-9edc-a4f3b98abbc8","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 41-10, October 1, 2015: Vaccines","revision_id":"3b479835-7966-4297-97f8-a9fb69adbfd4"}